Please login to the form below

Not currently logged in
Email:
Password:

BIO

This page shows the latest BIO news and features for those working in and with pharma, biotech and healthcare.

CAR-Ts take centre stage as ASH18 comes to a close

CAR-Ts take centre stage as ASH18 comes to a close

LCAR-B38M, including  an 88% overall response rate among a group of 57 patients that analysts suggest seems to hold up well against data presented by Bluebird Bio for its

Latest news

More from news
Approximately 10 fully matching, plus 161 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 26 partially matching documents found.

Latest appointments

More from appointments
Approximately 3 fully matching, plus 11 partially matching documents found.

Latest from PMHub

  • Random42 exhibiting at BIO-Europe 2018

    BIO-Europe attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts. ... For more information

  • A4P Bio Consulting Ltd

    A4P Bio Consulting Ltd.

  • Combination therapies in oncology: The benefits of integrated insights

    referencing their experience in oncology, demonstrate how integrated insights from payers, KOLs, community oncologists and patients can help support bio-pharma companies with oncology assets in all stages of clinical development.

  • The Biosimilar Challenge

    The ‘biosimilar challenge’ (or ‘bio battle’) is one of the most significant commercial changes we have seen in the pharma industry.

  • emotive. expands client services team

    Alongside his role at emotive. Rob is currently studying for an MSc in Bio-business at Birkbeck, University of London, with a focus on entrepreneurship in the bio-industry. .

More from PMHub
Approximately 2 fully matching, plus 25 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...

Infographics